TRAVERE THERAPEUTICS, INC. Investing Cash Flow
TRAVERE THERAPEUTICS, INC. (TVTX) reported Investing Cash Flow of -$184.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$206.29M, a 4353.34% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $21.55M, a 47.81% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$104.84M.
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $86.59M, a 87.73% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was $27.89M, a 71.92% decline from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was $99.33M, a 78.08% increase from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was $55.78M.
- TRAVERE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$32.55M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 10 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed | Net Cash Provided by (Used in) Investing Activities 22 month | Net Cash Provided by (Used in) Investing Activities 25 month | Net Cash Provided by (Used in) Investing Activities 28 month | Net Cash Provided by (Used in) Investing Activities 31 month | Net Cash Provided by (Used in) Investing Activities 34 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$206.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$184.74M 10-Q · filed 2026-08-04 | -$289.58M derived: sum of 3 quarters · filed 2026-08-04 | -$202.99M derived: sum of 4 quarters · filed 2026-08-04 | |||||||
| 2026-03-31 | $21.55M 10-Q · filed 2026-05-04 | -$83.29M derived: sum of 2 quarters · filed 2026-05-04 | $3.30M derived: sum of 3 quarters · filed 2026-05-04 | $8.15M derived: sum of 4 quarters · filed 2026-08-04 | |||||||
| 2025-12-31 | -$104.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$18.25M derived: sum of 2 quarters · filed 2026-02-19 | -$13.40M derived: sum of 3 quarters · filed 2026-08-04 | $27.89M 10-K · filed 2026-02-19 | |||||||
| 2025-09-30 | $86.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $91.44M derived: sum of 2 quarters · filed 2026-08-04 | $132.73M 10-Q · filed 2025-10-30 | $52.42M derived: sum of 4 quarters · filed 2026-08-04 | |||||||
| 2025-06-30 | $4.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $46.14M 10-Q · filed 2026-08-04 | -$34.17M derived: sum of 3 quarters · filed 2026-08-04 | $11.96M derived: sum of 4 quarters · filed 2026-08-04 | |||||||
| 2025-03-31 | $41.29M 10-Q · filed 2026-05-04 | -$39.02M derived: sum of 2 quarters · filed 2026-05-04 | $7.11M derived: sum of 3 quarters · filed 2026-05-04 | $35.72M derived: sum of 4 quarters · filed 2026-05-04 | |||||||
| 2024-12-31 | -$80.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$34.18M derived: sum of 2 quarters · filed 2026-02-19 | -$5.57M derived: sum of 3 quarters · filed 2026-02-19 | $99.33M 10-K · filed 2026-02-19 | |||||||
| 2024-09-30 | $46.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $74.74M derived: sum of 2 quarters · filed 2025-10-30 | $179.63M 10-Q · filed 2025-10-30 | $162.68M derived: sum of 4 quarters · filed 2026-02-19 | |||||||
| 2024-06-30 | $28.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $133.51M 10-Q · filed 2025-08-06 | $116.56M derived: sum of 3 quarters · filed 2026-02-19 | $249.88M derived: sum of 4 quarters · filed 2026-02-19 | |||||||
| 2024-03-31 | $104.90M 10-Q · filed 2025-05-01 | $87.95M derived: sum of 2 quarters · filed 2026-02-19 | $221.27M derived: sum of 3 quarters · filed 2026-02-19 | $197.71M derived: sum of 4 quarters · filed 2026-02-19 | |||||||
| 2023-12-31 | -$16.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $116.37M derived: sum of 2 quarters · filed 2026-02-19 | $92.81M derived: sum of 3 quarters · filed 2026-02-19 | $55.78M 10-K · filed 2026-02-19 | |||||||
| 2023-09-30 | $133.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $109.77M derived: sum of 2 quarters · filed 2024-10-31 | $72.73M 10-Q · filed 2024-10-31 | $36.02M derived: sum of 4 quarters · filed 2025-02-21 | |||||||
| 2023-06-30 | -$23.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$60.59M 10-Q · filed 2024-08-01 | -$97.29M derived: sum of 3 quarters · filed 2025-02-21 | -$87.21M derived: sum of 4 quarters · filed 2025-02-21 | |||||||
| 2023-03-31 | -$37.04M 10-Q · filed 2024-05-06 | -$73.74M derived: sum of 2 quarters · filed 2025-02-21 | -$63.66M derived: sum of 3 quarters · filed 2025-02-21 | -$102.76M derived: sum of 4 quarters · filed 2025-02-21 | |||||||
| 2022-12-31 | -$36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$26.62M derived: sum of 2 quarters · filed 2025-02-21 | -$65.72M derived: sum of 3 quarters · filed 2025-02-21 | -$32.55M 10-K · filed 2025-02-21 | |||||||
| 2022-09-30 | $10.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$29.02M derived: sum of 2 quarters · filed 2023-11-07 | $4.15M 10-Q · filed 2023-11-07 | $11.52M derived: sum of 4 quarters · filed 2024-02-20 | |||||||
| 2022-06-30 | -$39.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$5.93M 10-Q · filed 2023-08-03 | $1.44M derived: sum of 3 quarters · filed 2024-02-20 | $33.96M derived: sum of 4 quarters · filed 2024-02-20 | |||||||
| 2022-03-31 | $33.16M 10-Q · filed 2023-05-04 | $40.53M derived: sum of 2 quarters · filed 2024-02-20 | $73.06M derived: sum of 3 quarters · filed 2024-02-20 | $1.25M derived: sum of 4 quarters · filed 2024-02-20 | |||||||
| 2021-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $39.89M derived: sum of 2 quarters · filed 2024-02-20 | -$31.92M derived: sum of 3 quarters · filed 2024-02-20 | -$137.62M 10-K · filed 2024-02-20 | |||||||
| 2021-09-30 | $32.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$39.29M derived: sum of 2 quarters · filed 2022-10-27 | -$144.99M 10-Q · filed 2022-10-27 | -$270.50M derived: sum of 4 quarters · filed 2023-02-23 | |||||||
| 2021-06-30 | -$71.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$177.51M 10-Q · filed 2022-08-04 | -$303.02M derived: sum of 3 quarters · filed 2023-02-23 | -$346.19M derived: sum of 4 quarters · filed 2023-02-23 | |||||||
| 2021-03-31 | -$105.71M 10-Q · filed 2022-05-05 | -$231.22M derived: sum of 2 quarters · filed 2023-02-23 | -$274.39M derived: sum of 3 quarters · filed 2023-02-23 | -$206.58M derived: sum of 4 quarters · filed 2023-02-23 | |||||||
| 2020-12-31 | -$125.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$168.68M derived: sum of 2 quarters · filed 2023-02-23 | -$100.88M derived: sum of 3 quarters · filed 2023-02-23 | -$61.33M 10-K · filed 2023-02-23 | |||||||
| 2020-09-30 | -$43.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $24.63M derived: sum of 2 quarters · filed 2021-10-29 | $64.18M 10-Q · filed 2021-10-29 | $65.76M derived: sum of 4 quarters · filed 2022-02-24 | |||||||
| 2020-06-30 | $67.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $107.35M 10-Q · filed 2021-07-29 | $108.93M derived: sum of 3 quarters · filed 2022-02-24 | $113.40M derived: sum of 4 quarters · filed 2022-02-24 | |||||||
| 2020-03-31 | $39.55M 10-Q · filed 2021-05-06 | $41.13M derived: sum of 2 quarters · filed 2022-02-24 | $45.60M derived: sum of 3 quarters · filed 2022-02-24 | $70.83M derived: sum of 4 quarters · filed 2022-02-24 | |||||||
| 2019-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.04M derived: sum of 2 quarters · filed 2022-02-24 | $31.27M derived: sum of 3 quarters · filed 2022-02-24 | $19.86M 10-K · filed 2022-02-24 | |||||||
| 2019-09-30 | $4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $29.70M derived: sum of 2 quarters · filed 2020-11-05 | $18.28M 10-Q · filed 2020-11-05 | -$30.52M derived: sum of 4 quarters · filed 2021-03-01 | |||||||
| 2019-06-30 | $25.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $13.82M 10-Q · filed 2020-07-31 | -$34.98M derived: sum of 3 quarters · filed 2021-03-01 | -$196.53M derived: sum of 4 quarters · filed 2021-03-01 | |||||||
| 2019-03-31 | -$11.41M 10-Q · filed 2020-05-11 | -$60.21M derived: sum of 2 quarters · filed 2021-03-01 | -$221.76M derived: sum of 3 quarters · filed 2021-03-01 | -$193.85M derived: sum of 4 quarters · filed 2021-03-01 | |||||||
| 2018-12-31 | -$48.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$210.35M derived: sum of 2 quarters · filed 2021-03-01 | -$182.44M derived: sum of 3 quarters · filed 2021-03-01 | -$203.29M 10-K · filed 2021-03-01 | |||||||
| 2018-09-30 | -$161.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$133.64M derived: sum of 2 quarters · filed 2019-10-30 | -$154.49M 10-Q · filed 2019-10-30 | -$154.59M derived: sum of 4 quarters · filed 2020-02-24 | |||||||
| 2018-06-30 | $27.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.06M 10-Q · filed 2019-08-06 | $6.95M derived: sum of 3 quarters · filed 2020-02-24 | $4.76M derived: sum of 4 quarters · filed 2020-02-24 | |||||||
| 2018-03-31 | -$20.85M 10-Q · filed 2019-05-07 | -$20.95M derived: sum of 2 quarters · filed 2020-02-24 | -$23.14M derived: sum of 3 quarters · filed 2020-02-24 | ||||||||
| 2017-12-31 | -$103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$2.29M derived: sum of 2 quarters · filed 2020-02-24 | $45.60M 10-K · filed 2020-02-24 | ||||||||
| 2017-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $45.70M 10-Q · filed 2018-11-01 | |||||||||
| 2017-06-30 | $47.89M 10-Q · filed 2018-08-03 | ||||||||||
| 2016-12-31 | $10.37M 10-K · filed 2019-02-26 | ||||||||||
| 2015-12-31 | -$80.60M 10-K · filed 2018-07-06 | ||||||||||
| 2014-06-30 | -$6.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$37.17M 10-Q · filed 2014-08-14 | -$35.91M derived: sum of 3 quarters · filed 2015-07-09 | -$41.26M derived: sum of 4 quarters · filed 2015-07-09 | |||||||
| 2014-03-31 | -$31.11M 10-Q · filed 2014-05-15 | -$29.85M derived: sum of 2 quarters · filed 2015-07-09 | -$35.20M derived: sum of 3 quarters · filed 2015-07-09 | -$35.21M derived: sum of 4 quarters · filed 2015-07-09 | |||||||
| 2013-12-31 | $1.26M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2015-07-09 | -$4.09M derived: sum of 2 quarters · filed 2015-07-09 | -$4.10M derived: sum of 3 quarters · filed 2015-07-09 | -$5.41M 10-K/A · filed 2015-07-09 | -$7.12M 10-K/A · filed 2015-07-09 | ||||||
| 2013-09-30 | -$5.36M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2015-07-09 | -$5.36M derived: sum of 2 quarters · filed 2015-07-09 | -$6.67M 10-Q/A · filed 2015-07-09 | -$6.80M derived: sum of 4 quarters · filed 2015-07-09 | -$8.38M 10-Q/A · filed 2015-07-09 | ||||||
| 2013-06-30 | -$8.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.32M 10-Q · filed 2014-08-14 | -$1.45M derived: sum of 3 quarters · filed 2015-07-09 | -$1.74M derived: sum of 4 quarters · filed 2015-07-09 | -$2.88M 10-Q · filed 2013-09-16 | ||||||
| 2013-03-31 | -$1.31M 10-Q · filed 2014-05-15 | -$1.44M derived: sum of 2 quarters · filed 2015-07-09 | -$1.73M derived: sum of 3 quarters · filed 2015-07-09 | -$2.81M derived: sum of 4 quarters · filed 2015-07-09 | -$2.87M 10-Q/A · filed 2013-09-16 | ||||||
| 2012-12-31 | -$130.57K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2015-07-09 | -$419.63K derived: sum of 2 quarters · filed 2015-07-09 | -$1.50M derived: sum of 3 quarters · filed 2015-07-09 | -$1.70M 10-K/A · filed 2015-07-09 | $1.70M 10-K · filed 2013-06-13 | $1.71M 10-K/A · filed 2013-09-16 | |||||
| 2012-09-30 | -$289.06K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2015-07-09 | -$1.37M derived: sum of 2 quarters · filed 2015-07-09 | -$1.57M 10-Q/A · filed 2015-07-09 | ||||||||
| 2012-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-09-16 | -$1.28M 10-Q · filed 2013-09-16 | |||||||||
| 2012-03-31 | -$200.76K 10-Q/A · filed 2013-09-16 | ||||||||||
| 2011-12-31 | $12.87K 10-K/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |